Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 3.35 -1.18% -0.04
ORMP closed down 1.18 percent on Friday, May 22, 2020, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ORMP trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
180 Bullish Setup Bullish Swing Setup -1.18%
NR7 Range Contraction -1.18%
NR7-2 Range Contraction -1.18%
Inside Day Range Contraction -1.18%
NR7 Range Contraction 1.82%
Shooting Star Candlestick Bearish 1.82%
20 DMA Support Bullish 0.30%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Medicine Chemistry Pharmaceutical Pharmaceutical Industry Diabetes Medication Endocrine System Dosage Forms Insulin Peptide Hormones Treatment Of Diabetes Glucagon Like Peptide 1 Tablet Pharmaceutical Solutions

Is ORMP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.05
52 Week Low 2.31
Average Volume 104,469
200-Day Moving Average 3.73
50-Day Moving Average 3.09
20-Day Moving Average 3.22
10-Day Moving Average 3.33
Average True Range 0.23
ADX 21.85
+DI 20.20
-DI 12.01
Chandelier Exit (Long, 3 ATRs ) 2.95
Chandelier Exit (Short, 3 ATRs ) 3.44
Upper Bollinger Band 3.58
Lower Bollinger Band 2.85
Percent B (%b) 0.68
BandWidth 22.66
MACD Line 0.05
MACD Signal Line 0.03
MACD Histogram 0.0187
Fundamentals Value
Market Cap 44.62 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.53
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.54
Resistance 3 (R3) 3.55 3.49 3.51
Resistance 2 (R2) 3.49 3.44 3.49 3.50
Resistance 1 (R1) 3.42 3.41 3.39 3.41 3.49
Pivot Point 3.37 3.37 3.35 3.36 3.37
Support 1 (S1) 3.30 3.32 3.27 3.29 3.21
Support 2 (S2) 3.24 3.29 3.24 3.20
Support 3 (S3) 3.17 3.24 3.19
Support 4 (S4) 3.16